Skip to main content

Loading market data...

ELV

Elevance Health, Inc.

NYSE • United states

$440.18

+$9.95

(+2.31%)

Source: Yahoo Finance · Quote time Oct 20, 2026 20:00 GMT+0000

Catalyst Evidence

No verified catalyst stored yet

Click “View” to see the stored chain of evidence (if available).

Management
Credibility
Score

Elevance Health, Inc. (ELV)

Unavailable

Quotes may be delayed

$95.46B

Market Cap

1,546,655

Volume

19.2

P/E Ratio

1.58%

Div Yield

Elevance Health, Inc. Price Chart

Loading price history…

Management Credibility Analysis

Unavailable

Verified Management Score Unavailable

Management credibility requires sourced guidance and earnings history.

Upcoming Catalysts

Verified event feed

Verified Catalysts Unavailable

No sourced upcoming event feed is configured for this stock yet.

Company profile

No description available

Chief executive: Not disclosed
Headquarters: 220 VIRGINIA AVENUE, INDIANAPOLIS, IN
Founded: Not disclosed

📈 Company Timeline

Major business events

Positive

Negative

Neutral

21 Oct 2026

Elevance Health, Inc. filed Form 10-Q

Elevance Health, Inc. submitted Form 10-Q to the SEC for the period ending Sep 30, 2026.

21 Oct 2026

Elevance Health, Inc. reported Operating or financial results

Elevance Health, Inc. filed an 8-K covering operating or financial results, supporting financial statements or exhibits.

10 Sep 2026

Elevance Health, Inc. reported Regulation FD disclosure

Elevance Health, Inc. filed an 8-K covering Regulation FD disclosure.

15 Jul 2026

Elevance Health, Inc. filed Form 10-Q

Elevance Health, Inc. submitted Form 10-Q to the SEC for the period ending Jun 30, 2026.

15 Jul 2026

Elevance Health, Inc. reported Operating or financial results

Elevance Health, Inc. filed an 8-K covering operating or financial results, supporting financial statements or exhibits.

Capital Structure & Financial Position

Financial strength and liquidity analysis

Cash and equivalents (USD)$10.23B

Total assets (USD)$126.44B

Total liabilities (USD)$81.42B

Shareholders' equity (USD)$44.88B

Long-term debt (USD)$30.67B

Debt due within a year (USD)$375.00M

Source: SEC EDGAR company facts (opens in a new tab) Balance sheet dated 30 Jun 2026

Peer Comparison - Health Care

Company	Price	Market Cap
LLY - Eli Lilly and Company	$1,276.13 Yahoo Finance	$1.20T
JNJ - Johnson & Johnson	$256.74 Yahoo Finance	$618.71B
ABBV - AbbVie Inc.	$284.80 Yahoo Finance	$503.28B
UNH - UnitedHealth Group Incorporated	$418.43 Yahoo Finance	$375.58B
MRK - Merck & Co., Inc.	$148.55 Yahoo Finance	$366.50B

📋 Corporate Actions

Recent and upcoming corporate events

Verified Corporate Actions Unavailable

Dividend, buyback, split, and spin-off feeds are not ingested for this stock yet.

Financials

Financial statements and key metrics analysis

Quarter	Revenue (USD)	Operating income	Net income	Diluted EPS (USD)	Filed
Q2 2026	$50.47B	$1.76B	$1.46B	$6.71	10-Q · 15 Jul 2026
Q1 2026	$50.18B	$2.09B	$1.76B	$8.00	10-Q · 22 Apr 2026
Q4 2025	$49.75B	$309.00M	$547.00M	Unavailable	10-K · 6 Feb 2026
Q3 2025	$50.71B	$1.30B	$1.19B	$5.32	10-Q · 21 Oct 2025
Q2 2025	$49.78B	$2.43B	$1.74B	$7.72	10-Q · 17 Jul 2025
Q1 2025	$48.89B	$3.17B	$2.18B	$9.61	10-Q · 22 Apr 2025

Source: SEC EDGAR company facts (opens in a new tab)

Analyst Consensus

Buy

Target: $464.86

5.6% upside potential

📈

Strong Buy

Unavailable

👍

Buy

6

⏸️

Hold

2

📉

Sell

0

8 analysts covering this stock

Source: Nasdaq analyst research (opens in a new tab) Retrieved 21 Oct 2026, 04:49 UTC Targets range 424.00–488.00 Ratings are third-party opinions, not advice.

💰 Upcoming Dividends

Next dividend payments

Verified Dividend Data Unavailable

Dividend calendar data is not ingested for this stock yet.

Guidance Evolution

Verified Guidance History Unavailable

Verified company guidance history is not ingested for this stock yet.

💼 Director Transactions

Recent insider activity

2

Oct 2026

Kaye Mark

EVP & CFO

Tax withholding

$386.43 per share

4,161 shares

2

Oct 2026

Kaye Mark

EVP & CFO

Grant or award

Unavailable per share

2,627 shares

3

Sep 2026

Wessling Erin M

EVP & Chief Legal Officer

Tax withholding

$414.78 per share

255 shares

2

Sep 2026

Wessling Erin M

EVP & Chief Legal Officer

Tax withholding

$405.84 per share

94 shares

2

Sep 2026

Craig Ryan R

EVP & Chief HR Officer

Tax withholding

$405.84 per share

144 shares

17

Jul 2026

PERU RAMIRO G

Director

Open-market purchase

$366.05 per share

1,000 shares

17

Jul 2026

BOUDREAUX GAIL

Director, President and CEO

Open-market purchase

$367.79 per share

2,725 shares

12

Jun 2026

Penczek Ronald W

CAO & Controller

Open-market sale

$403.16 per share

369 shares

11

Jun 2026

Dixon Robert L JR

Director

Open-market sale

$401.77 per share

151 shares

19

May 2026

Penczek Ronald W

CAO & Controller

Option exercise

$294.30 per share

1,531 shares

Top Shareholders

Vanguard Group Inc

23,019,518 shares

0.091% change

12/31/2025

Blackrock, Inc.

18,991,090 shares

-4.506% change

6/30/2026

Vanguard Capital Management Llc

14,058,204 shares

-2.002% change

6/30/2026

State Street Corp

10,426,610 shares

1.34% change

6/30/2026

Wellington Management Group Llp

9,213,513 shares

11.97% change

6/30/2026

Vanguard Portfolio Management Llc

6,214,356 shares

-2.23% change

6/30/2026

Sanders Capital, Llc

5,825,024 shares

-1.175% change

6/30/2026

Geode Capital Management, Llc

5,166,124 shares

-0.512% change

6/30/2026

Harris Associates L P

4,924,511 shares

2.668% change

6/30/2026

Artisan Partners Limited Partnership

4,581,222 shares

-10.648% change

6/30/2026

Source: Nasdaq institutional holdings (opens in a new tab) Observed 21 Oct 2026, 04:49 UTC· 1 day ago

Research coverage and investment tools

Elevance Health, Inc. (ELV) is a stock listed on the New York Stock Exchange in the United States, in the Health Care sector (Medical Specialities). Its last price was US$440.18 on 20 Oct 2026. That is 100% of the way from its 52-week low of US$274.84 to its 52-week high of US$440.67. It paid US$6.87 a share in dividends over the last 12 months, a dividend yield of 1.58%. The latest ex-dividend date on file is 10 Sep 2026. Its market capitalisation was US$95.46 billion at that price.

Watch Add to portfolio Set an alert Compare Position size

How position sizing works Dividend yield and total return

Quarter	Revenue	Operating income	Net income	Diluted EPS	Gross margin	Operating margin	Free cash flow	Filed
Q2 2026	$50.47B	$1.76B	$1.46B	$6.71	—	3.5%	$1.63B	10-Q · 15 Jul 2026 (opens in a new tab)
Q1 2026	$50.18B	$2.09B	$1.76B	$8.00	—	4.2%	$4.10B	10-Q · 22 Apr 2026 (opens in a new tab)
Q4 2025	$49.75B	$309.00M	$547.00M	Unavailable	—	0.6%	−$209.00M	10-K · 6 Feb 2026 (opens in a new tab)
Q3 2025	$50.71B	$1.30B	$1.19B	$5.32	—	2.6%	$775.00M	10-Q · 21 Oct 2025 (opens in a new tab)
Q2 2025	$49.78B	$2.43B	$1.74B	$7.72	—	4.9%	$1.79B	10-Q · 17 Jul 2025 (opens in a new tab)
Q1 2025	$48.89B	$3.17B	$2.18B	$9.61	—	6.5%	$821.00M	10-Q · 22 Apr 2025 (opens in a new tab)

Cash and equivalents: $10.23B
Total assets: $126.44B
Total liabilities: $81.42B
Shareholders' equity: $44.88B
Long-term debt: $30.67B
Debt due within a year: $375.00M

10-Q · 21 Oct 2026

Elevance Health, Inc. filed Form 10-Q (opens in a new tab)

Elevance Health, Inc. submitted Form 10-Q to the SEC for the period ending Sep 30, 2026.
8-K · 21 Oct 2026

Elevance Health, Inc. reported Operating or financial results (opens in a new tab)

Elevance Health, Inc. filed an 8-K covering operating or financial results, supporting financial statements or exhibits.
8-K · 10 Sep 2026

Elevance Health, Inc. reported Regulation FD disclosure (opens in a new tab)

Elevance Health, Inc. filed an 8-K covering Regulation FD disclosure.
10-Q · 15 Jul 2026

Elevance Health, Inc. filed Form 10-Q (opens in a new tab)

Elevance Health, Inc. submitted Form 10-Q to the SEC for the period ending Jun 30, 2026.
8-K · 15 Jul 2026

Elevance Health, Inc. reported Operating or financial results (opens in a new tab)

Elevance Health, Inc. filed an 8-K covering operating or financial results, supporting financial statements or exhibits.

Insider	Date	Transaction	Shares	Average price	Filing
Kaye Mark EVP & CFO	2 Oct 2026	Tax withholding (F)	−4,161	$386.43	Form 4 (opens in a new tab)
Kaye Mark EVP & CFO	2 Oct 2026	Grant or award (A)	+2,627	—	Form 4 (opens in a new tab)
Wessling Erin M EVP & Chief Legal Officer	3 Sep 2026	Tax withholding (F)	−255	$414.78	Form 4 (opens in a new tab)
Wessling Erin M EVP & Chief Legal Officer	2 Sep 2026	Tax withholding (F)	−94	$405.84	Form 4 (opens in a new tab)
Craig Ryan R EVP & Chief HR Officer	2 Sep 2026	Tax withholding (F)	−144	$405.84	Form 4 (opens in a new tab)
PERU RAMIRO G Director	17 Jul 2026	Open-market purchase (P)	+1,000	$366.05	Form 4 (opens in a new tab)
BOUDREAUX GAIL Director, President and CEO	17 Jul 2026	Open-market purchase (P)	+2,725	$367.79	Form 4 (opens in a new tab)
Penczek Ronald W CAO & Controller	12 Jun 2026	Open-market sale (S)	−369	$403.16	Form 4 (opens in a new tab)
Dixon Robert L JR Director	11 Jun 2026	Open-market sale (S)	−151	$401.77	Form 4 (opens in a new tab)
Penczek Ronald W CAO & Controller	19 May 2026	Option exercise (M)	+1,531	$294.30	Form 4 (opens in a new tab)

Institution	Report date	Shares	Change
Vanguard Group Inc	12/31/2025	23,019,518	0.091%
Blackrock, Inc.	6/30/2026	18,991,090	-4.506%
Vanguard Capital Management Llc	6/30/2026	14,058,204	-2.002%
State Street Corp	6/30/2026	10,426,610	1.34%
Wellington Management Group Llp	6/30/2026	9,213,513	11.97%
Vanguard Portfolio Management Llc	6/30/2026	6,214,356	-2.23%
Sanders Capital, Llc	6/30/2026	5,825,024	-1.175%
Geode Capital Management, Llc	6/30/2026	5,166,124	-0.512%
Harris Associates L P	6/30/2026	4,924,511	2.668%
Artisan Partners Limited Partnership	6/30/2026	4,581,222	-10.648%

Previous close: 430.23 USD
Day range: 431.09 – 440.67 USD
52-week range: 274.84 – 440.67 USD
Volume: 1,546,655
Market cap: $95.46B
P/E ratio: 19.2
EPS (FY 2025, diluted): 25.21 USD
Dividends (last 12 months): 6.87 USD
Dividend yield: 1.58%
Ex-dividend date: 10 Sep 2026
Shares outstanding: 216.87M
Beta (5Y monthly): 0.63

Price, ranges and volume: Yahoo Finance (opens in a new tab) Observed 20 Oct 2026, 20:00 UTC· 1 day ago

Average volume and shares: Nasdaq (opens in a new tab) Observed 22 Oct 2026, 06:32 UTC· 34 seconds ago

Dividends: Yahoo Finance dividend history (opens in a new tab) Observed 22 Oct 2026, 06:32 UTC· 34 seconds ago

P/E is market cap ÷ trailing 12-month net income from SEC filings.

EPS: SEC EDGAR company facts (opens in a new tab)

Beta: 5 years of monthly returns against the S&P 500, calculated from Yahoo Finance prices. Market cap is the price × shares outstanding. What dividend yield leaves out: dividend yield vs total return

This research is not available for ELV yet

Guidance history

IMPORTANT FINANCIAL DISCLAIMER: The information provided on this platform is for educational and informational purposes only and should not be construed as investment advice. All investments involve risk, including potential loss of principal. Past performance does not guarantee future results. Take Profits is not a registered investment advisor and does not provide personalized investment advice. Users should conduct their own research and consult with qualified financial professionals before making investment decisions. Market data may be delayed and is provided by third-party sources.